Sign in
CompletedNo phase

Intra-articular Administration of Med Device Made of Biological Vegetal Matrix for the Treatment of Knee Osteoarthritis

Key facts

Who runs it
Bios-Therapy, Physiological Systems for Health S.p.A
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
150 people enrolled
Started
6 Dec 2022
Ended
10 Oct 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Medical Device Iniettabile Ginocchio
Record updated
17 April 2025

Who can take part

Age
40 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Signed Informed Consent
  • Patient of both sexes over 40 years of age
  • Diagnosis of primary osteoarthritis of the knee according to the criteria of the American College, radiologically confirmed, i.e., one or more osteophytes and a measurable joint space on a standard radiograph taken within 3 months prior to screening
  • Score ≥2 in the target knee on a Likert scale at WOMAC pain question 1 (i.e. pain while walking on a flat surface) at the V-1 screening visit (to be confirmed at the V0 baseline visit). The target knee is defined as the knee with osteoarthritis in the case of unilateral pathology or the only one with this criterion in the case of bilateral pathology
  • Severity grade of arthrosis 2 or 3 according to Kellgren \& Lawrence classification
  • Be willing to maintain stable eating habits and lifestyle throughout the study period

Who cannot take part

  • Intake of analgesics, NSAIDs or opioids within 5 days prior to the start of the run-in (i.e. prior to V-1)
  • Cycle of treatment with systemic corticosteroids or intra-articular corticosteroid injection in any joint in the 3 months prior to screening
  • Abuse of alcohol, narcotics or psychotropic drugs that can alter the state of vigilance and physical perception
  • Previous participation in a clinical study within the last 30 days
  • Presence of autoimmune diseases (excluding chronic autoimmune thyroiditis) or other chronic inflammatory processes (e.g. rheumatoid arthritis, ongoing infections, gout)
  • Ongoing infections
  • Established or presumed allergy to hyaluronic acid, echinacea or centella
  • Patients with malignant neoplasms of any kind, or with a history of malignant neoplasms except for patients with a positive history of a malignant neoplasm that has been surgically removed and has not recurred within five years prior to study participation
  • Dementia of any kind or other possible causes of progressive deterioration of the mental soundness, or any psychological or physical disability that reduces the ability to take the treatment under study as intended
  • Inadequate reliability or presence of conditions that may lead to non- compliance/adherence of the patient to the protocol
  • Body Mass Index (BMI) ≥ 30 kg/m2
  • Pregnant women
  • Intra-articular visco supplementation in the target knee in the preceding 9 months
  • Symptomatic arthrosis of the contralateral knee with a score ≥3 on a Likert scale to WOMAC pain question 1 (pain while walking on a flat surface) at V-1 (to be confirmed at V0), or severe symptomatic hip arthrosis
  • Significant deformity: genu varum, ligament laxity or meniscus instability

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A pre-market randomized, parallel group, single-blind, clinical study with a Medical Device, made of vegetal material, to evaluate the efficacy and safety of one knee injection of the investigational device versus active comparator (Jonexa). The study population will consist of 150 patients diagnosed with primary knee osteoarthrosis. At present, the study is monocentric competitive.

Read full original descriptionShow less

Treatment period for each patient is 6 months.

The 2 groups in the trial

  • Experimental ArmTreatment being tested

    Arm: Medical Device Iniettabile Ginocchio

    Treatment: Medical Device Iniettabile Ginocchio

  • Comparator ArmExisting treatment, for comparison

    Arm: Medical Device Jonexa (active comparator medical device from the market )

    Treatment: Medical Device Iniettabile Ginocchio

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized, Parallel Group, Single Blind Clinical Trial Against Active Comparator to Evaluate the Efficacy and Safety of a Medical Device Made of a Vegetal Biological Matrix for the Treatment of Knee Osteoarthritis.
Record updated
17 April 2025